Skip Navigation

Publicaciones covid-9

Resource Feedback

If you know about a problem with one of our resource records, we want to know about it!

Resource Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
URL https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/fulltext
(if you would like a response)
Verification Code:
CAPTCHA Image
Reload Image